$80K — $100K *
Seattle Genetics is a global multi-product biotechnology company that develops and commercializes innovative antibody-based therapies for the treatment of cancer. The company’s industry-leading antibody-drug conjugate (ADC) technology harnesses the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. In addition to three marketed products, we are advancing a strong product pipeline of novel therapies for solid tumors and blood related cancers designed to address significant unmet medical needs and improve treatment outcomes for patients. More information about Seattle Genetics can be found at www.seattlegentics.com.
This position will be responsible for supporting clinical trials and the development strategy for Tisotumab Vedotin. The successful candidate should have demonstrated proficiency in leading clinical trials and supporting development programs, in addition to being adept at managing relationships across collaborations and with the external clinical community.
As the leading employer in our industry in the Pacific Northwest, Seattle Genetics is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.
Valid through: 12/15/2020
$100K — $150K
7 days ago